О. В. Аверков
Impact in
-
- Heart Failure Treatment and Management
- Acute Myocardial Infarction Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiovascular Function and Risk Factors
- Cardiac electrophysiology and arrhythmias
Papers in
-
- Antiplatelet Therapy and Cardiovascular Diseases 8
- Acute Myocardial Infarction Research 8
- Heart Failure Treatment and Management 5
-
- COVID-19 Clinical Research Studies 7
- SARS-CoV-2 and COVID-19 Research 4
- Co-authors
- Е.П. Павликова (6 shared papers)Diego Albrecht (3 shared papers)Yu. V. Kotovskaya (2 shared papers)Surya Ayalasomayajula (1 shared paper)Pierre J. Jordaan (1 shared paper)Priya Chandra (1 shared paper)Iris Rajman (1 shared paper)Thomas Langenickel (1 shared paper)
- Journals
- Circulation (4 papers)American Heart Journal (2 papers)Clinical Cardiology (2 papers)Circulation Cardiovascular Interventions (1 paper)Atherosclerosis (1 paper)
- Partner nations
- RussiaUnited StatesCanada
In The Last Decade
О. В. Аверков
32 papers receiving 193 citations
Peers
Comparison fields: 5 of 51
- Cardiology and Cardiovascular Medicine 123
- Internal Medicine 10
- Endocrinology, Diabetes and Metabolism 20
- Modeling and Simulation 4
- Complementary and alternative medicine 6
Countries citing papers authored by О. В. Аверков
This map shows the geographic impact of О. В. Аверков's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by О. В. Аверков with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites О. В. Аверков more than expected).
Fields of papers citing papers by О. В. Аверков
This network shows the impact of papers produced by О. В. Аверков. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by О. В. Аверков. The network helps show where О. В. Аверков may publish in the future.
Co-authors
The 25 scholars most cited alongside О. В. Аверков, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 66 | |
| 2 | 2023 | 22 | |
| 3 | 2019 | 17 | |
| 4 | 2019 | 11 | |
| 5 | 2023 | 10 | |
| 6 | 2022 | 8 | |
| 7 | Natriuretic peptide inhibition in the presence of angioten-sin receptor blockade following short-term treatment with LCZ 696 in heart failure patients: effect on ANP, BNP, NT-proBNP and cGMP | 2011 | 6 |
| 8 | 2018 | 5 | |
| 9 | [Non ST elevation acute coronary syndrome: early use of pravastatin or atorvastatin is associated with divergent changes of parameters of hemostasis]. | 2003 | 5 |
| 10 | 2015 | 5 | |
| 11 | Abstract 19378: First Experience with Concomitant AT1 and Neprilysin (NEP 24.11) Inhibition with LCZ696 in Patients with Chronic Heart Failure | 2010 | 4 |
| 12 | 2022 | 4 | |
| 13 | [Diagnostic value of heart fatty-acid binding protein in early hospitalized patients with non ST elevation acute coronary syndrome]. | 2003 | 4 |
| 14 | [Unstable angina: effect of aspirin and heparin on treatment outcome in hospital patients (a double-blind, placebo-controlled study)]. | 1993 | 4 |
| 15 | 2017 | 4 | |
| 16 | [Markers of inflammation and platelet aggregation in patients with non ST elevation acute coronary syndrome treated with atorvastatin or pravastatin]. | 2003 | 3 |
| 17 | 2022 | 3 | |
| 18 | 2020 | 2 | |
| 19 | 2020 | 2 | |
| 20 | 2024 | 2 |
About О. В. Аверков
О. В. Аверков is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases, Surgery, Internal Medicine and Radiology, Nuclear Medicine and Imaging, having authored 50 papers that have together received 202 indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (8 papers), Acute Myocardial Infarction Research (8 papers), COVID-19 Clinical Research Studies (7 papers), Venous Thromboembolism Diagnosis and Management (6 papers), Heart Failure Treatment and Management (5 papers), Healthcare Systems and Public Health (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Long-Term Effects of COVID-19 (4 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (123 citations), Internal Medicine (10 citations), Endocrinology, Diabetes and Metabolism (20 citations), Modeling and Simulation (4 citations) and Complementary and alternative medicine (6 citations). О. В. Аверков has collaborated with scholars based in Russia, United States and Canada. Frequent co-authors include Е.П. Павликова, Diego Albrecht, Yu. V. Kotovskaya, Surya Ayalasomayajula, Pierre J. Jordaan, Priya Chandra, Iris Rajman, Thomas Langenickel, Margaret F. Prescott and Parasar Pal. Their work appears in journals such as Circulation, American Heart Journal, Clinical Cardiology, Circulation Cardiovascular Interventions and Atherosclerosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.